CU20110219A7 - Composiciones y métodos para administración de vacunas contra virus del dengue - Google Patents
Composiciones y métodos para administración de vacunas contra virus del dengueInfo
- Publication number
- CU20110219A7 CU20110219A7 CU20110219A CU20110219A CU20110219A7 CU 20110219 A7 CU20110219 A7 CU 20110219A7 CU 20110219 A CU20110219 A CU 20110219A CU 20110219 A CU20110219 A CU 20110219A CU 20110219 A7 CU20110219 A7 CU 20110219A7
- Authority
- CU
- Cuba
- Prior art keywords
- compositions
- den
- methods
- intradermal
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención reporta composiciones y métodos para vacunar a un sujeto contra virus del dengue. En algunas modalidades, las composiciones de vacuna puden ser administradas por introducción intradérmica. En ciertas modalidades, la introducción intradérmica en un sujeto de una vacuna contra el virus de dengue puede incluir uno o más refuerzos intradérmicos después de la vacunación inicial. Otras modalidades incluyen la inyección intradérmica de una composición de vacuna contra el virus del dengue en donde la composición proporciona protección contra dos o más de DEN-1, DEN-2, DEN-3 y DEN-4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18302009P | 2009-06-01 | 2009-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20110219A7 true CU20110219A7 (es) | 2012-06-21 |
Family
ID=43220488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20110219A CU20110219A7 (es) | 2009-06-01 | 2011-11-29 | Composiciones y métodos para administración de vacunas contra virus del dengue |
Country Status (17)
Country | Link |
---|---|
US (2) | US9211323B2 (es) |
EP (1) | EP2438198A4 (es) |
JP (2) | JP5848243B2 (es) |
KR (1) | KR101876304B1 (es) |
CN (2) | CN102449172A (es) |
AU (3) | AU2010256845B2 (es) |
CA (1) | CA2763944A1 (es) |
CL (1) | CL2011003043A1 (es) |
CO (1) | CO6470882A2 (es) |
CU (1) | CU20110219A7 (es) |
IL (2) | IL216706A0 (es) |
MX (1) | MX343172B (es) |
MY (1) | MY184428A (es) |
NZ (2) | NZ597000A (es) |
PH (1) | PH12016502431A1 (es) |
SG (1) | SG176299A1 (es) |
WO (1) | WO2010141386A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013188315A1 (en) * | 2012-06-10 | 2013-12-19 | Inviragen, Inc. | Compositions and methods for administration of vaccines against dengue virus |
US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
KR101876304B1 (ko) * | 2009-06-01 | 2018-07-10 | 다케다 백신즈 인코포레이티드 | 뎅기 바이러스에 대한 백신 투여용 조성물 및 방법 |
JP2016504315A (ja) * | 2012-12-14 | 2016-02-12 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 三価デングウイルス製剤に関する組成物、投与方法および使用 |
PL3539565T3 (pl) | 2013-03-15 | 2023-09-25 | Takeda Vaccines, Inc. | Kompozycje i sposoby dla konstruktów chimerycznych wirusa dengi w szczepionkach |
EP3442571A1 (en) | 2016-04-13 | 2019-02-20 | Takeda Vaccines, Inc. | Compositions and methods of vaccination against dengue virus in children and young adults |
US11576962B2 (en) | 2017-12-21 | 2023-02-14 | Green Biomed, Inc. | Cross-immunizing antigen vaccine and method for preparation thereof |
WO2020051334A1 (en) | 2018-09-05 | 2020-03-12 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE310824T1 (de) * | 1991-09-19 | 2005-12-15 | Chimäre und/oder wachstumsgehemmte flaviviren | |
FR2741077B1 (fr) * | 1995-11-14 | 1998-01-23 | Pasteur Institut | Vaccin polyvalent anti-dengue |
MXPA01009683A (es) * | 1999-03-26 | 2003-06-24 | Army | Vacuna multivalente del virus del dengue. |
ES2374131T3 (es) | 2000-02-16 | 2012-02-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Flavivirus quiméricos avirulentos e inmunógenos. |
EP1159969A1 (fr) * | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
DK2290109T3 (da) | 2001-05-22 | 2014-11-10 | Us Gov Health & Human Serv | Udvikling af mutationer, der er anvendelige til svækkelse af dengue-vira samt kimære dengue-vira |
GB0123580D0 (en) * | 2001-10-01 | 2001-11-21 | Glaxosmithkline Biolog Sa | Vaccine |
US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
AU2003239932A1 (en) | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
US8029802B2 (en) * | 2004-10-20 | 2011-10-04 | Sanofi Pasteur Biologics Co. | Vaccines against Japanese encephalitis virus and West Nile virus |
US8110196B2 (en) | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
US7618393B2 (en) * | 2005-05-03 | 2009-11-17 | Pharmajet, Inc. | Needle-less injector and method of fluid delivery |
ATE475706T1 (de) * | 2005-06-17 | 2010-08-15 | Sanofi Pasteur | Abgeschwächter dengue-serotyp-2-stamm |
CN101287490B (zh) * | 2005-08-10 | 2013-04-24 | 阿坎姆比斯公司 | 对抗登革热病毒感染的疫苗接种 |
JP5227172B2 (ja) * | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
WO2008022196A2 (en) * | 2006-08-15 | 2008-02-21 | Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health Andhuman Services, The | Development of dengue virus vaccine components |
FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
WO2008085288A1 (en) * | 2007-01-11 | 2008-07-17 | Sealed Air Corporation (Us) | Method of shaping insulation |
US20100316670A1 (en) | 2007-06-14 | 2010-12-16 | Blaney Joseph E | Chimeric sle/dengue type 4 antigenic viruses |
KR101876304B1 (ko) | 2009-06-01 | 2018-07-10 | 다케다 백신즈 인코포레이티드 | 뎅기 바이러스에 대한 백신 투여용 조성물 및 방법 |
US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
-
2010
- 2010-05-28 KR KR1020117031022A patent/KR101876304B1/ko active IP Right Grant
- 2010-05-28 US US12/790,511 patent/US9211323B2/en not_active Expired - Fee Related
- 2010-05-28 MX MX2011012807A patent/MX343172B/es active IP Right Grant
- 2010-05-28 EP EP10783881.5A patent/EP2438198A4/en not_active Withdrawn
- 2010-05-28 SG SG2011088788A patent/SG176299A1/en unknown
- 2010-05-28 CN CN2010800241489A patent/CN102449172A/zh active Pending
- 2010-05-28 CA CA2763944A patent/CA2763944A1/en not_active Abandoned
- 2010-05-28 NZ NZ597000A patent/NZ597000A/en not_active IP Right Cessation
- 2010-05-28 MY MYPI2011005768A patent/MY184428A/en unknown
- 2010-05-28 WO PCT/US2010/036726 patent/WO2010141386A1/en active Application Filing
- 2010-05-28 NZ NZ618158A patent/NZ618158A/en not_active IP Right Cessation
- 2010-05-28 AU AU2010256845A patent/AU2010256845B2/en not_active Ceased
- 2010-05-28 CN CN201711026301.1A patent/CN107913406A/zh active Pending
- 2010-05-28 JP JP2012513332A patent/JP5848243B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-29 CU CU20110219A patent/CU20110219A7/es unknown
- 2011-11-30 IL IL216706A patent/IL216706A0/en not_active IP Right Cessation
- 2011-12-01 CL CL2011003043A patent/CL2011003043A1/es unknown
- 2011-12-12 CO CO11170641A patent/CO6470882A2/es not_active Application Discontinuation
-
2015
- 2015-11-06 US US14/935,281 patent/US10010600B2/en not_active Expired - Fee Related
- 2015-11-26 JP JP2015230723A patent/JP2016033151A/ja active Pending
- 2015-12-17 IL IL243204A patent/IL243204A0/en unknown
-
2016
- 2016-12-05 PH PH12016502431A patent/PH12016502431A1/en unknown
- 2016-12-22 AU AU2016277660A patent/AU2016277660A1/en not_active Abandoned
-
2019
- 2019-01-11 AU AU2019200212A patent/AU2019200212A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ618158A (en) | 2015-05-29 |
MX343172B (es) | 2016-10-26 |
KR101876304B1 (ko) | 2018-07-10 |
US10010600B2 (en) | 2018-07-03 |
AU2019200212A1 (en) | 2019-01-31 |
JP2016033151A (ja) | 2016-03-10 |
IL216706A0 (en) | 2012-02-29 |
US20160129102A1 (en) | 2016-05-12 |
CO6470882A2 (es) | 2012-06-29 |
AU2016277660A1 (en) | 2017-01-12 |
EP2438198A1 (en) | 2012-04-11 |
WO2010141386A1 (en) | 2010-12-09 |
PH12016502431A1 (en) | 2019-02-11 |
NZ597000A (en) | 2014-07-25 |
SG176299A1 (en) | 2012-01-30 |
US9211323B2 (en) | 2015-12-15 |
CA2763944A1 (en) | 2010-12-09 |
AU2010256845B2 (en) | 2016-09-22 |
MX2011012807A (es) | 2012-01-30 |
US20100303860A1 (en) | 2010-12-02 |
JP2012528794A (ja) | 2012-11-15 |
JP5848243B2 (ja) | 2016-01-27 |
CL2011003043A1 (es) | 2012-07-20 |
CN107913406A (zh) | 2018-04-17 |
IL243204A0 (en) | 2016-02-29 |
EP2438198A4 (en) | 2014-05-14 |
KR20120027396A (ko) | 2012-03-21 |
MY184428A (en) | 2021-04-01 |
AU2010256845A1 (en) | 2011-12-22 |
CN102449172A (zh) | 2012-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20110219A7 (es) | Composiciones y métodos para administración de vacunas contra virus del dengue | |
BRPI0913012A2 (pt) | vírus do nilo ocidental/da dengue quiméricos | |
AR093421A1 (es) | Composiciones, metodos y usos de construcciones de virus del dengue de serotipo-4 | |
MX336687B (es) | Tratamiento y prevencion de infecciones del virus del dengue. | |
ECSP14013315A (es) | Inhibidores de aplicación viral | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
UY33797A (es) | Composiciones farmacéuticas para el tratamiento del vhc | |
PE20140646A1 (es) | Vacuna de virus de dengue inactivado | |
AR095598A1 (es) | Composiciones y métodos para construcciones quiméricas del virus del dengue en vacunas | |
PH12015502230B1 (en) | Novel viral replication inhibitors | |
EP2294192A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT AND VACCINATION AGAINST DENGUE VIRUS (DV) | |
CO6511253A2 (es) | Vacuna de paramixovirus aviar recombinante y metodo para producri y usar la misma | |
CA2915027A1 (en) | Compositions and methods for administration of vaccines against dengue virus | |
PH12016500465A1 (en) | Deoxynojirimycin derivatives and methods of their using | |
BR112018068342A2 (pt) | vacina de vírus zika vivo atenuado | |
BR112015031226A2 (pt) | Composição de vacina, e, uso da composição de vacina | |
WO2013012835A3 (en) | Sirna useful in the treatment of flavivirus infection | |
CO2017005830A2 (es) | Composiciones de vacuna para el virus del dengue | |
ECSP12012131A (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quiméricos | |
UY35418A (es) | Vacuna que proporciona protección frente a diferentes Picornavirus humanos. | |
BR112016029201A2 (pt) | vírus do oeste do nilo/dengue quiméricos e métodos de uso | |
AR082057A1 (es) | Vacunas de enterovirus para prevenir o tratar diabetes tipo 1 (i) | |
TH91621B (th) | วิธีการของการก่อภูมิคุ้มกันโรคเพื่อต่อต้าน 4 ซีโรไทป์ของไข้เลือดออก | |
TH137870A (th) | องค์ประกอบและวิธีการสำหรับการให้ของวัคซีนต่อต้านไวรัสเดงกี่ (dengue virus) | |
NI201400025A (es) | Inhibidores de aplicación viral |